Role of the melanocortin system in inflammation

Annals of the New York Academy of Sciences

Volumn 1072, Issue , 2006, Pages 123-134

  Maaser, Christian ^a,b   Kannengiesser, Klaus ^a   Kucharzik, Torsten ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b NONE   (Germany)

Author keywords

Colitis; Intestinum; KPV; Melanocortin; MSH

Indexed keywords

MELANOCORTIN; MELANOCORTIN RECEPTOR; MESSENGER RNA;

ANTIINFLAMMATORY ACTIVITY; COLITIS; CONFERENCE PAPER; ENTERITIS; GASTROINTESTINAL TRACT; HUMAN; IMMUNOMODULATION; INFLAMMATION; LUNG; NONHUMAN; SKIN; SKIN PIGMENTATION;

EID: 33749006607     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1326.016     Document Type: Conference Paper

References (65)

1. CATANIA, A., S. GATTI, G. COLOMBO, et al. 2004. Targeting melanocortin receptors as a novel strategy to control inflammation. Pharmacol. Rev. 56: 1-29.
2. GETTING, S.J. 2002. Melanocortin peptides and their receptors: new targets for anti-inflammatory therapy. Trends Pharmacol. Sci. 23: 447-449.
3. PRITCHARD, L.E., A.V. TURNBULL & A. WHITE. 2002. Pro-opiomelanocortin processing in the hypothalamus: impact on melanocortin signalling and obesity. J. Endocrinol. 172: 411-421.
4. THODY, A.J., K. RIDLEY, R.J. PENNY, et al. 1983. MSH peptides are present in mammalian skin. Peptides 4: 813-816.
5. WINTZEN, M. & B.A. GILCHREST. 1996. Proopiomelanocortin, its derived peptides, and the skin. J. Invest. Dermatol. 106: 3-10.
6. LUGER, T.A., T. BRZOSKA, T.E. SCHULZEN, et al. 2000. The role of alpha-MSH as a modulator of cutaneous inflammation. Ann. N. Y. Acad. Sci. 917: 232-238.
7. BHARDWAJ, R.S. & T.A. LUGER. 1994. Proopiomelanocortin production by epidermal cells: evidence for an immune neuroendocrine network in the epidermis. Arch. Dermatol. Res. 287: 85-90.
8. BOTCHKAREV, V.A., N.V. BOTCHKAREVA & A. SLOMINSKI. 1999. Developmentally regulated expression of alpha-MSH and MC-1 receptor in C57BL/6 mouse skin suggests functions beyond pigmentation. Ann. N. Y. Acad. Sci. 885: 433-439.
9. SCHOLZEN, T.E., D.H. KALDEN & T. BRZOSKA. 2000. Expression of proopiomelanocortin peptides in human dermal microvascular endothelial cells: evidence for a regulation by ultraviolet light and interleukin-1. J. Invest. Dermatol. 115: 1021-1028.
10. NEUMANN ANDERSEN, G., O. NAGAEVA, I. MANDRIKA, et al. 2001. MC(1) receptors are constitutively expressed on leucocyte subpopulations with antigen presenting and cytotoxic functions. Clin. Exp. Immunol. 126: 441-446.
11. SLOMINSKI, A., J. WORTSMAN, T. LUGER, et al. 2000. Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress. Physiol. Rev. 80: 979-1020.
12. MOUNTJOY, K.G., L.S. ROBBINS, M.T. MORTRUD, et al. 1992. The cloning of a family of genes that encode the melanocortin receptors. Science 257: 1248-1251.
13. CHHAJLANI, V. & J.E. WIKBERG. 1992. Molecular cloning and expression of the human melanocyte stimulating hormone receptor cDNA. FEBS Lett. 309: 417-420.
14. STAR, R.A., N. RAJORA, J. HUANG, et al. 1995. Evidence of autocrine modulation of macrophage nitric oxide synthase by alpha-melanocyte-stimulating hormone. Proc. Natl. Acad. Sci. USA 92: 8016-8020.
15. CATANIA, A., N. RAJORA, F. CAPSONI, et al. 1996. The neuropeptide alpha-MSH has specific receptors on neutrophils and reduces chemotaxis in vitro. Peptides 17: 675-679.
16. BECHER, E., K. MAHNKE, T. BRZOSKA, et al. 1999. Human peripheral blood-derived dendritic cells express functional melanocortin receptor MC-1R. Ann. N. Y. Acad. Sci. 885: 188-195.
17. LUGER, T.A., T. SCHULZEN, T. BRZOSKA, et al. 1998. Cutaneous immunomodulation and coordination of skin stress responses by alpha-melanocyte-stimulating hormone. Ann. N. Y. Acad. Sci. 840: 381-394.
18. MOUNTJOY, K.G. 1994. The human melanocyte stimulating hormone receptor has evolved to become "super-sensitive" to melanocortin peptides. Mol. Cell. Endocrinol. 102: R7-R11.
19. MANNA, S.K. & B.B. AGGARWAL. 1998. Alpha-melanocyte-stimulating hormone inhibits the nuclear transcription factor NF-kappa B activation induced by various inflammatory agents. J. Immunol. 161: 2873-2880.
20. MAASER, C., K. KANNENGIESSER, C. SPECHT, et al. 2006. Crucial role of the melanocortin receptor MC1R in experimental colitis. Gut. E-publication ahead of print.
21. XIA, Y. & J.E. WIKBERG. 1996. Localization of ACTH receptor mRNA by in situ hybridization in mouse adrenal gland. Cell. Tissue. Res. 286: 63-68.
22. BUCKLEY, D.I. & J. RAMACHANDRAN. 1981. Characterization of corticotropin receptors on adrenocortical cells. Proc. Natl. Acad. Sci. USA 78: 7431-7435.
23. TSIGOS, C., K. ARAI, W. HUNG, et al. 1993. Hereditary isolated glucocorticoid deficiency is associated with abnormalities of the adrenocorticotropin receptor gene. J. Clin. Invest. 92: 2458-2461.
24. KONDA, Y., I. GANTZ, J. DEL VALLE, et al. 1994. Interaction of dual intracellular signaling pathways activated by the melanocortin-3 receptor. J. Biol. Chem. 269: 13162-13166.
25. GANTZ, I., Y. KONDA, T. TASHIRO, et al. 1993. Molecular cloning of a novel melanocortin receptor. J. Biol. Chem. 268: 8246-8250.
26. CHHAJLANI, V. 1996. Distribution of cDNA for melanocortin receptor subtypes in human tissues. Biochem. Mol. Biol. Int. 38: 73-80.
27. LOW, M.J. 2004. Role of proopiomelanocortin neurons and peptides in the regulation of energy homeostasis. J. Endocrinol. Invest. 27(6 Suppl): 95-100.
28. CHEN, A.S., D.J. MARSH, M.E. TRUMBAUER, et al. 2000. Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass. Nat. Genet. 26: 97-102.
29. GETTING, S.J., H.C. CHRISTIAN, R.J. FLOWER, et al. 2002. Activation of melanocortin type 3 receptor as a molecular mechanism for adrenocorticotropic hormone efficacy in gouty arthritis. Arthritis. Rheum. 46: 2765-2775.
30. GETTING, S.J., H.C. CHRISTIAN, C.W. LAM, et al. 2003. Redundancy of a functional melanocortin 1 receptor in the anti-inflammatory actions of melanocortin peptides: studies in the recessive yellow (e/e) mouse suggest an important role for melanocortin 3 receptor. J. Immunol. 170: 3323-3330.
31. GETTING, S.J., G.H. ALLCOCK, R. FLOWER, et al. 2001. Natural and synthetic agonists of the melanocortin receptor type 3 possess anti-inflammatory properties. J. Leukoc. Biol. 69: 98-104.
32. GETTING, S.J., L. GIBBS, A.J. CLARK, et al. 1999. POMC gene-derived peptides activate melanocortin type 3 receptor on murine macrophages, suppress cytokine release, and inhibit neutrophil migration in acute experimental inflammation. J Immunol 162: 7446-7453.
33. FAROOQI, I.S., J.M. KEOGH, G.S. YEO, et al. 2003. Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. N. Engl. J. Med. 348: 1085-1095.
34. BRANSON, R., N. POTOCZNA, J.G. KRAL, et al. 2003. Binge eating as a major phenotype of melanocortin 4 receptor gene mutations. N. Engl. J. Med. 348: 1096-1103.
35. HUSZAR, D., C.A. LYNCH, V. FAIRCHILD-HUNTRESS, et al. 1997. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 88: 131-141.
36. MARSH, D.J., G. HOLLOPETER, D. HUSZAR, et al. 1999. Response of melanocortin-4 receptor-deficient mice to anorectic and orexigenic peptides. Nat. Genet. 21: 119-122.
37. MOUNTJOY, K.G., M.T. MORTRUD, M.J. LOW, et al. 1994. Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain. Mol. Endocrinol. 8: 1298-1308.
38. GANTZ, I., H. MIWA, Y. KONDA, et al. 1993. Molecular cloning, expression, and gene localization of a fourth melanocortin receptor. J. Biol. Chem. 268: 15174-15179.
39. VAN DER PLOEG, L.H., W.J. MARTIN, A.D. HOWARD, et al. 2002. A role for the melanocortin 4 receptor in sexual function. Proc. Natl. Acad. Sci. USA 99: 11381-11386.
40. CHEN, W., M.A. KELLY, X. OPITZ-ARAYA, et al. 1997. Exocrine gland dysfunction in MC5-R-deficient mice: evidence for coordinated regulation of exocrine gland function by melanocortin peptides. Cell 91: 789-798.
41. BUGGY, J.J. 1998. Binding of alpha-melanocyte-stimulating hormone to its G-protein-coupled receptor on B-lymphocytes activates the Jak/STAT pathway. Biochem. J. 331: 211-216.
42. ADACHI, S., T. NAKANO, H. VLIAGOFTIS, et al. 1999. Receptor-mediated modulation of murine mast cell function by alpha-melanocyte stimulating hormone. J. Immunol. 163: 3363-3368.
43. LUGER, T.A., T.E. SCHOLZEN, T. BRZOSKA, et al. 2003. New insights into the functions of alpha-MSH and related peptides in the immune system. Ann. N. Y. Acad. Sci. 994: 133-140.
44. LUGER, T.A., R.S. BHARDWAJ, S. GRABBE, et al. 1996. Regulation of the immune response by epidermal cytokines and neurohormones. J. Dermatol. Sci. 13: 5-10.
45. MANNA, S.K., A. SARKAR & Y. SREENIVASAN. 2006. Alpha-melanocyte- stimulating hormone down-regulates CXC receptors through activation of neutrophil elastase. Eur. J. Immunol.
46. KALDEN, D.H., T. SCHOLZEN, T. BRZOSKA, et al. 1999. Mechanisms of the antiinflammatory effects of alpha-MSH: role of transcription factor NF-kappa B and adhesion molecule expression. Ann. N. Y. Acad. Sci. 885: 254-261.
47. ICHIYAMA, T., T. SAKAI, A. CATANIA, et al. 1999. Inhibition of peripheral NF-kappaB activation by central action of alpha-melanocyte-stimulating hormone. J. Neuroimmunol. 99: 211-217.
48. ICHIYAMA, T., I.L. CAMPBELL, S. FURUKAWA, et al. 1999. Autocrine alpha-melanocyte-stimulating hormone inhibits NF-kappaB activation in human glioma. J. Neurosci. Res. 58: 684-689.
49. GETTING, S.J., H.B. SCHIOTH & M. PERRETTI. 2003. Dissection of the anti-inflammatory effect of the core and C-terminal (KPV) alpha-melanocyte- stimulating hormone peptides. J. Pharmacol. Exp. Ther. 306: 631-637.
50. CUTULI, M., S. CRISTIANI, J.M. LIPTON, et al. 2000. Antimicrobial effects of alpha-MSH peptides. J. Leukoc. Biol. 67: 233-239.
51. CATANIA, A., M. CUTULI, L. GAROFALO, et al. 2000. Plasma concentrations and anti-L-cytokine effects of alpha-melanocyte stimulating hormone in septic patients. Crit. Care. Med. 28: 1403-1407.
52. SLOMINSKI, A., J. WORTSMAN, J.E. MAZURKIEWICZ, et al. 1993. Detection of proopiomelanocortin-derived antigens in normal and pathologic human skin. J. Lab. Clin. Med. 122: 658-666.
53. SLOMINSKI, A., R. PAUS & J. WORTSMAN. 1993. On the potential role of proopiomelanocortin in skin physiology and pathology. Mol. Cell. Endocrinol. 93: C1-C6.
54. BAYERL, C., J. LAUK, I. MOLL, et al. 1997. Immunohistochemical characterization of HSP, alpha-MSH, Merkel cells and neuronal markers in acute UV dermatitis and acute contact dermatitis in vivo. Inflamm. Res. 46: 409-411.
55. GRABBE, S., R.S. BHARDWAJ, K. MAHNKE, et al. 1996. Alpha-melanocyte- stimulating hormone induces hapten-specific tolerance in mice. J. Immunol. 156: 473-478.
56. RHEINS, L.A., A.L. COTLEUR, R.S. KLEIER, et al. 1998. Alpha-melanocyte stimulating hormone modulates contact hypersensitivity responsiveness in C57/BL6 mice. J. Invest. Dermatol. 93: 511-517.
57. ICHIYAMA, T., K. OKADA, I.L. CAMPBELL, et al. 2000. NF-kappaB activation is inhibited in human pulmonary epithelial cells transfected with alpha-melanocyte-stimulating hormone vector. Peptides 21: 1473-1477.
58. RAAP, U., T. BRZOSKA, S. SOHL, et al. 2003. Alpha-melanocyte-stimulating hormone inhibits allergic airway inflammation. J. Immunol. 171: 353-359.
59. COLOMBO, G., R. BUFFA, M.T. BARDELLA, et al. 2002. Anti-inflammatory effects of alpha-melanocyte-stimulating hormone in celiac intestinal mucosa. Neuroimmunomodulation 10: 208-216.
60. HASSOUN, H.T., L. ZOU, F.A. MOORE, et al. 2002. Alpha-melanocyte- stimulating hormone protects against mesenteric ischemia-reperfusion injury. Am. J. Physiol. Gastrointest. Liver Physiol. 282: G1059-G1068.
61. ZOU, L., B. ATTUWAYBI & B.C. KONE. 2003. Effects of NF-kappa B inhibition on mesenteric ischemia-reperfusion injury. Am. J. Physiol. Gastrointest. Liver Physiol. 284: G713-G721.
62. SAN, T., B.K. OKTAR, E. SALIK, et al. 2001. The effect of alpha-melanocyte stimulating hormone on endotoxin-induced intestinal injury. Peptides 22: 2077-2082.
63. RAJORA, N., G. BOCCOLI, A. CATANIA, et al. 1997. Alpha-MSH modulates experimental inflammatory bowel disease. Peptides 18: 381-385.
64. OKTAR, B.K., F. ERCAN, B.C. YEGEN, et al. 2000. The effect of alpha-melanocyte stimulating hormone on colonic inflammation in the rat. Peptides 21: 1271-1277.
65. ROBBINS, L.S., J.H. NADEAU, K.R. JOHNSON, et al. 1993. Pigmentationphenotypes of variant extension locus alleles result from point mutations that alter MSH receptor function. Cell 72: 827-834.